Komori
Zuiko (6279) · InitiativeFirst stated

Establishment of 上海瑞光創科医療健康科技有限公司 to Build a Sales Structure for Medical Supplies in China

First written in FY2026-H1. . Latest entry: FY2026-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Building a China sales channel for medical supplies through 上海瑞光創科医療健康科技A theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1First statedAnnual report

    「To expand sales in China, we reviewed our structure and decided to establish a sales subsidiary in Shanghai responsible for the Chinese market.」

    上海瑞光創科医療健康科技有限公司 was established on 28 August 2025 with 100% investment from 瑞光（上海）電気設備有限公司. It has stated capital of RMB50 million and sells medical devices and medical products. The Group plans to sell products from ZUIKO MEDICAL and establish sales channels in China for wound dressings such as Plasmoist.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Zuiko yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.